Advanced Search

column
Chinese Expert Consensus on Oncology Multimorbidity Management (2025 Edition)
Chinese Society of Clinical Oncology (CSCO) Committee of Experts on Cancer Supportive and Rehabilitation Therapy
2025, 52(11): 879-912. DOI: 10.3971/j.issn.1000-8578.2025.25.0771
Abstract PDF
Developing Effective Strategies to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer by Directly Targeting Cancer Cells
HUANG Qing, XIAO Jiaqi, HU Sheng, CAI Qian
2025, 52(11): 913-925. DOI: 10.3971/j.issn.1000-8578.2025.25.0508
Abstract PDF
Strategies to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer: Targeting Non-Cancer Cells
CHEN Runzhi, XUE Chang, LI Xiaoyu, LI Yuanxiang, HU Sheng
2025, 52(11): 926-936. DOI: 10.3971/j.issn.1000-8578.2025.25.0506
Abstract PDF
Resistance to Immunotherapy in Non-Small Cell Lung Cancer: Intricate Mechanisms
WU Jingyi, ZHANG Xiaoyan, HU Sheng, ZHONG Yi
2025, 52(11): 937-944. DOI: 10.3971/j.issn.1000-8578.2025.25.0507
Abstract PDF
Clinical Effects of Intercostal Nerve Block Analgesia and Patient Controlled Intravenous Analgesia in Enhanced Recovery After Minimally Invasive Surgery for Lung Cancer: A Prospective Randomized Controlled Trial
ZHAO Ziyi, YE Yun, CHEN Xi, TIAN Long, ZHENG Xi, CHE Guowei
2025, 52(11): 945-950. DOI: 10.3971/j.issn.1000-8578.2025.25.0278
Abstract PDF
From Immune Microenvironment to Targeted Precision Therapy: New Strategies for Treatment of Pancreatic Cancer
YU Haiyan, ZHANG Huojun
2025, 52(11): 951-958. DOI: 10.3971/j.issn.1000-8578.2025.25.0358
Abstract PDF

This work is licensed under a Creative Commons Attribution 3.0 License.

Email Alert RSS
Total visits： Visits today：